Verified Nov 2026
Other
·
Bedford, Massachusetts
·
Since 1992
Anika Therapeutics, Inc. manufactures hyaluronic acid-based products for orthopedic joint preservation, including osteoarthritis pain management, regenerative tissue repair, and sports medicine treatments. Headquartered in Bedford, Massachusetts, the publicly traded company was founded in 1992 and employs between 200 and 500 people. It serves medical, automotive, electric-vehicle, renewable-energy, and industrial equipment sectors. Its Orthovisc and Monovisc products are part of its portfolio, and it operates facilities in Indiana and Abano Terme, Italy.
Anika at a glance
Revenue
112.8M
Employees
200-500
Founded
1992
Headquarters
Bedford, Massachusetts
Ownership
Publicly traded (NASDAQ: ANIK)
Certifications
ISO 13485
Import activity
17
Industries
Automotive
Electric Vehicles
Medical
Renewable Energy
Industrial Equipment
Sourcing and import activity
From US customs bill-of-lading records
US sea imports
17
Named foreign suppliers
6
Top origins
Italy · Germany · Belgium
Shared foreign counterparties do not establish that these companies buy from Anika.
What this tells a buyer
Anika's most recent reported developments include its second quarter 2026 financial results, released July 29, 2026, and first quarter 2026 results, released April 28, 2026.
The company holds ISO 13485 certification and focuses on hyaluronic acid products such as Orthovisc and Monovisc for early intervention orthopedic care.
Anika is publicly traded under the ticker ANIK and reports annual revenue in the range of $112.8 million.
Source: US customs bill-of-lading records and public filings · Last verified Nov 05, 2026
STABILITY SIGNALS
Established & strong
34 years in operation (founded 1992).
Publicly listed; no distress event on record.
Holds ISO 13485 certification(s) per public sources.
Overview
Anika Therapeutics, Inc. manufactures hyaluronic acid-based products for orthopedic joint preservation, including osteoarthritis pain management, regenerative tissue repair, and sports medicine treatments. Headquartered in Bedford, Massachusetts, the publicly traded company was founded in 1992 and employs between 200 and 500 people. It serves medical, automotive, electric-vehicle, renewable-energy, and industrial equipment sectors. Its Orthovisc and Monovisc products are part of its portfolio, and it operates facilities in Indiana and Abano Terme, Italy.
At a glance
Attribute | Detail |
|---|---|
Founded | 1992 |
Headquarters | Bedford, Massachusetts |
Employees | 200-500 |
Revenue | 112.8M |
Ownership | Publicly traded (NASDAQ: ANIK) |
Certifications | ISO 13485 |
What Anika makes
The company holds ISO 13485 certification and focuses on hyaluronic acid products such as Orthovisc and Monovisc for early intervention orthopedic care.
Certifications
Anika is associated with the following certifications in public sources. Confirm the certified scope for the specific plant producing your part:
ISO 13485 — anika.com
Trade and customs footprint
Anika's most recent reported developments include its second quarter 2026 financial results, released July 29, 2026, and first quarter 2026 results, released April 28, 2026. US customs bill-of-lading records list 17 inbound shipments across 6 foreign suppliers, with top origins including Italy · Germany · Belgium.
Latest developments
2026-08-03 — Anika Therapeutics Advances Manufacturing Capacity Amid Customer Concentration Risks — Anika Therapeutics, Inc. — $ANIK (valye.com)
2026-07-29 — Anika Reports Second Quarter 2026 Financial Results | Markets Insider (businessinsider.com)
2026-07-29 — Anika Therapeutics Inc (ANIK) Q2 2026 Earnings Call Highlights: Record Revenue and Margin ... (yahoo.com)
2026-04-28 — Anika Reports First Quarter 2026 Financial Results (anika.com)
2026-03-02 — Anika Therapeutics refocuses on HA orthopedics | ANIK Annual Report (10-K) (stocktitan.net)
2026-02-26 — Anika Reports Fourth Quarter and Full Year 2025 Financial Results (anika.com)
Facilities
Anika is headquartered in Bedford, Massachusetts. Public sources also reference these locations:
Abano Terme, Italy — anika.com
Company details
Anika is publicly traded under the ticker ANIK and reports annual revenue in the range of $112.8 million. Anika was founded in 1992, has an estimated 200-500 employees, and is headquartered in Bedford, Massachusetts. On the LightSource stability read it is rated "Established & strong": 34 years in operation (founded 1992). Publicly listed; no distress event on record. Holds ISO 13485 certification(s) per public sources.
Frequently asked questions
What does Anika do?
Anika Therapeutics, Inc. manufactures hyaluronic acid-based products for orthopedic joint preservation, including osteoarthritis pain management, regenerative tissue repair, and sports medicine treatments. Headquartered in Bedford, Massachusetts, the publicly traded company was founded in 1992 and employs between 200 and 500 people. It serves medical, automotive, electric-vehicle, renewable-energy, and industrial equipment sectors. Its Orthovisc and Monovisc products are part of its portfolio, and it operates facilities in Indiana and Abano Terme, Italy.
Where is Anika headquartered?
Anika is headquartered in Bedford, Massachusetts (32 Wiggins Avenue, Bedford, Massachusetts, 01730).
When was Anika founded?
Anika was founded in 1992.
How big is Anika?
Anika has an estimated 200-500 employees, with revenue in the 112.8M range.
Is Anika publicly traded?
Publicly traded (NASDAQ: ANIK). Public financial figures are drawn from its filings.
What certifications does Anika hold?
Anika lists ISO 13485 on its website. Confirm the certified scope for the specific plant producing your part.
Related suppliers
Explore other suppliers in the LightSource directory:
Last verified Nov 2026. Is this your company? Request a correction.
Location & contact
Evaluating suppliers like these?
This profile comes from a public-data sample of around 1,000 companies. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.